Eventually, RFS results obtained from Cox regression analysis indicated that WDR43 constituted a statistically significant risk factor for PAAD, LIHC, LUAD, LUSC, KIRP, and UCEC patients and a protective factor against BLCA, KIRC, ovarian serous cystadenocarcinoma (OV) and STAD patients (Figure S1D, Supplemental Digital Content, http://links.lww.com/MD/N284). Here, WDR43 is linked to bladder transitional cell carcinoma.